Trademark: 79312359
Status Date
Tuesday, July 5, 2022
Registration Number
6776851
Registration Date
Tuesday, July 5, 2022
Filing Date
Thursday, February 11, 2021
Published for Opposition
Tuesday, April 19, 2022
5 Reagents for immunoanalysis for medical use; preparations for pharmaceutical purposes; preparations for medical purposes; chemical-pharmaceutical preparations for pharmaceutical or medical purposes; diagnostic preparations for medical purposes, reagents for medical and veterinary purposes; vaccines; biochemical analysis preparations for medical purposes and the aforementioned preparations all for development and analysis of vaccines, immunotherapy and cellular therapy, namely, cancer vaccines and cancer immunotherapy, and T cell therapies; biochemical analysis preparations for pharmaceutical or medical purposes for use in cancer therapy or other therapy, for the analysis of T cell infiltration of solid tumors and tissue, as well as infectious diseases, and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T cell monitoring, all for medical or veterinary purposes
1 Reagents for scientific and research use, namely, reagents for immunoanalysis, not for medical use; chemical products for diagnostic, industrial and scientific purposes, namely, Diagnostic reagents and preparations, except for medical or veterinary use, Chemicals for use in industry and science, Chemical preparations for general industrial manufacturing; diagnostic reagents for scientific diagnostic not for medical and veterinary purposes; research reagents for scientific and diagnostic research purposes; diagnostic test materials for scientific and diagnostic purposes not for medical or veterinary purposes, namely, Diagnostic preparations, other than for medical or veterinary purposes, Diagnostic reagents for scientific or research use, Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; biochemical reagents used for non-medical purposes; chemical reagents, other than for medical or veterinary purposes; biochemical diagnostic kits for scientific and diagnostic purposes not for medical or veterinary purposes comprised of biochemical reagents used for non-medical purposes; biochemical analysis kits for research and diagnostic purposes not for medical and veterinary purposes comprised of biochemicals for in vitro and in vivo scientific use; biochemical analysis preparations for scientific purposes related to vaccines and immunotherapy, including cancer therapy, cancer immunotherapy, analysis or treatment of cancer, infectious diseases and/or autoimmunity, and for use in connection with toxicological studies, transplantation, and immune monitoring and T cell monitoring
42 Scientific and technological analyses of T cells and their responses, namely, research services and design of T cells and their responses; industrial analysis of T cells and their responses, including for development of medicines and vaccines; basic scientific and clinical research on T cells and their responses, including for the development of medicines and vaccines
Oct 18, 2022
Final Disposition Notice Sent To Ib
Oct 18, 2022
Final Disposition Processed
Oct 5, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jul 5, 2022
Notice Of Registration Confirmation Emailed
Jul 5, 2022
Registered-Principal Register
May 3, 2022
Notification Processed By Ib
Apr 19, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 19, 2022
Published For Opposition
Apr 13, 2022
Notification Of Possible Opposition Sent To Ib
Apr 13, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 30, 2022
Notification Of Notice Of Publication E-Mailed
Mar 14, 2022
Assigned To Lie
Mar 11, 2022
Approved For Pub - Principal Register
Mar 10, 2022
Examiner's Amendment Entered
Mar 10, 2022
Notification Of Examiners Amendment E-Mailed
Mar 10, 2022
Examiners Amendment E-Mailed
Mar 10, 2022
Examiners Amendment -Written
Feb 11, 2022
Teas/Email Correspondence Entered
Feb 10, 2022
Correspondence Received In Law Office
Feb 10, 2022
Teas Response To Office Action Received
Oct 25, 2021
Refusal Processed By Ib
Sep 27, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Sep 27, 2021
Refusal Processed By Mpu
Sep 14, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Sep 13, 2021
Non-Final Action Written
Sep 8, 2021
Assigned To Examiner
Jun 11, 2021
Application Filing Receipt Mailed
Jun 7, 2021
New Application Office Supplied Data Entered In Tram
Jun 3, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
